We transplanted STAG2 mutated (p.K983*) UM-UC-3 bladder cancer cells, which were transduced with in vitro validated shRNAs targeting STAG1, into immunocompromised mice to evaluate the effects of partial STAG1 suppression in vivo (Fig S2A–D). This evidence concerns the gene STAG2 and urinary bladder cancer.